Sabra Health Care REIT (FRA:SBC) Growth Rank: 8 (As of Aug. 30, 2026) — 100% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:SBC Sabra Health Care REIT Inc FRA:SBC
84 GF Score
Price €17.58
GF Value €17.50
Valuation Fairly Valued
! 11 Warning Signs
View Full Analysis

What is Sabra Health Care REIT Growth Rank?

Sabra Health Care REIT FRA:SBC -1.43% 84 Growth Rank is 8 as of Aug. 30, 2026, which is 100% above its 10-year median of 4.00. GuruFocus rates FRA:SBC with a GF Score™ of 84/100 and a GF Value™ of €17.50 (Fairly Valued). The stock has 11 warning signs investors should review.

Sabra Health Care REIT has the Growth Rank of 8.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Sabra Health Care REIT Growth Rank Related Terms

FRA:SBC vs HR, NHI, MPT: Growth Rank Comparison

For the REIT - Healthcare Facilities subindustry, Sabra Health Care REIT's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sabra Health Care REIT Growth Rank vs REITs Industry

For the REITs industry and Real Estate sector, Sabra Health Care REIT's Growth Rank distribution charts can be found below:

* The bar in red indicates where Sabra Health Care REIT's Growth Rank falls into.


FRA:SBC
84GF Score
Sabra Health Care REIT Inc FRA:SBC
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 8 mean?
Sabra Health Care REIT (FRA:SBC) has a Growth Rank of 8 as of Aug. 30, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Sabra Health Care REIT and its competitors. This is 100% above median its historical median of 4.00. Over the past decade, Sabra Health Care REIT's Growth Rank has ranged from 1.00 to 10.00.
Is Sabra Health Care REIT's Growth Rank too high?
Sabra Health Care REIT's current Growth Rank of 8 is 100% above median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, Sabra Health Care REIT has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sabra Health Care REIT's Growth Rank compare to HR and NHI?
Sabra Health Care REIT's Growth Rank of 8 can be compared against companies in the REITs industry. Historically, Sabra Health Care REIT's own Growth Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a REITs company?
A good Growth Rank depends on the REITs industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Sabra Health Care REIT and its competitors. Sabra Health Care REIT's current Growth Rank is 8, which is 100% above median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sabra Health Care REIT stock overvalued right now?
Based on GuruFocus' analysis, Sabra Health Care REIT (FRA:SBC) is currently considered Fairly Valued. The stock's GF Value™ is €17.50, compared to a current price of €17.58 — trading 0.5% above its estimated fair value. The current Growth Rank is 8, which is 100% above median its 10-year median of 4.00. Sabra Health Care REIT's overall GF Score™ is 84/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Sabra Health Care REIT (FRA:SBC), the current Growth Rank is 8 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sabra Health Care REIT (FRA:SBC) Overvalued in 2026?

Based on GuruFocus' analysis, Sabra Health Care REIT stock appears to be overvalued. The current stock price of €17.58 is trading 0.5% above its estimated GF Value™ of €17.50. GuruFocus considers Sabra Health Care REIT to be Fairly Valued.

Key valuation signals for FRA:SBC:

  • Growth Rank: 8 (100% above median its 10-year median of 4.00)
  • GF Value™: €17.50 vs. price of €17.58 (0.5% above fair value)
  • GF Score™: 84/100 with 11 warning signs

No single metric tells the full story. See the FRA:SBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sabra Health Care REIT Business Description

Industry Real EstateREITs
Other Exchanges SBRA:USA
Address 1781 Flight Way, Tustin, CA, USA, 92782
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
84GF Score

Get the complete analysis for FRA:SBC

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.58
Price
€17.50
GF Value